Quince Therapeutics (QNCX) Appoints Charles S Ryan as President streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Palisade Bio (NASDAQ:PALI – Get Free Report) and Quince Therapeutics (NASDAQ:QNCX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability. Profitability This table compares Palisade Bio and […]
Quince Therapeutics (NASDAQ:QNCX – Get Free Report) and Palisade Bio (NASDAQ:PALI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Insider & Institutional Ownership 31.1% of Quince […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond acquired 24,766 shares of Quince Therapeutics stock in a transaction on Thursday, August 17th. The stock was purchased at an average price of $1.29 per share, with a total value of $31,948.14. Following the transaction, the director now directly owns 2,097,109 shares in the […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond purchased 24,766 shares of Quince Therapeutics stock in a transaction that occurred on Thursday, August 17th. The shares were bought at an average cost of $1.29 per share, for a total transaction of $31,948.14. Following the completion of the transaction, the director now directly […]